Art

J-GLOBAL ID：201702216089468634   Reference number：17A1819492

Significance of perivascular tumour cells defined by CD109 expression in progression of glioma

神経膠腫の進行におけるCD109の発現により定義された血管周囲腫瘍細胞の意義【Powered by NICT】

Author (20)： Shiraki Yukihiro (Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Mii Shinji (Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Enomoto Atsushi (Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Momota Hiroyuki (Division of Innovative Cancer Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan) ,  Han Yi-Peng (Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Kato Takuya (Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Ushida Kaori (Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Kato Akira (Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Asai Naoya (Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Murakumo Yoshiki (Department of Pathology, Kitasato University School of Medicine, Sagamihara, Japan) ,  Aoki Kosuke (Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Aoki Kosuke (Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Suzuki Hiromichi (Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Suzuki Hiromichi (Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Ohka Fumiharu (Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Wakabayashi Toshihiko (Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Todo Tomoki (Division of Innovative Cancer Therapy, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan) ,  Ogawa Seishi (Department of Pathology and Tumor Biology, Graduate School of Medicine, Kyoto University, Kyoto, Japan) ,  Natsume Atsushi (Department of Neurosurgery, Nagoya University Graduate School of Medicine, Nagoya, Japan) ,  Takahashi Masahide (Department of Pathology, Nagoya University Graduate School of Medicine, Nagoya, Japan)
Material： Journal of Pathology  (J Pathol)
Volume： 243  Issue： 4  Page： 468-480  Publication year： 2017 
JST Material Number： B0171A  ISSN： 0022-3417  CODEN： JPTLA  Document type： Article
Article type： 原著論文  Country of issue： United States (USA)  Language： ENGLISH (EN)

Abstract/Point： In the progression of glioma, ...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A1819492&from=J-GLOBAL&jstjournalNo=B0171A") }}

Thesaurus term： *glioma ,  human ,  *blood vessel ,  therapy ,  *tumor cell ,  growth stimulation ,  World Health Organization ,  Cancer Stem Cell ,  mouse model ,  controlling element ,  clinical pathology ,  brain tumor stem cell ,  microenvironment ,  nitrogen heterocyclic compound ,  urea compound ,  carboxamide
Semi thesaurus term： 治療標的 , 【Automatic Indexing@JST】

Author keywords (4)： glioma ,  tumour microenvironment ,  brain tumour stem cells ,  CD109

JST classification (3)： Biological function  (EB03040U) ,  Cell physiology in general  (EF02010S) ,  Basic oncology in general  (GE02010R)

Substance index (1)： Temozolomide

Terms in the title (6)： 神経膠腫 ,  CD109 ,  発現 ,  定義 ,  血管 ,  腫瘍細胞